Cost-cutting helps Cyberonics shrink quarter 1 loss
This article was originally published in Clinica
Cyberonics narrowed its net loss for the first quarter of fiscal 2008, as the company's cost-savings initiatives - implemented during the quarter - begin to take effect.
You may also be interested in...
Latest warning to Humaworm notes findings that FDA inspectors made in July 2019. FDA officials apparently have been in Humaworm’s facility since then, executing a search warrant in October and confiscating encapsulating machines, herbs, capsules, computers, and records.
After a tepid performance in the fiscal fourth quarter, Torrent expects its key markets India, US and Brazil to be impacted by the COVID-19 fallout as well as a lack of visibility on regulatory approvals for its manufacturing facilities.
Biotronik recently hired its first-ever chief medical officer, former Mayo Clinic medical director David Hayes, as part of a bid to deepen the Berlin-based firm’s relationships in the US. Here’s what company president Ryan Walters said about the American market.